Zobrazeno 1 - 10
of 39
pro vyhledávání: '"S. Schwarzenböck"'
Publikováno v:
Theranostics, Vol 2, Iss 1, Pp 318-330 (2012)
PET and PET/CT using [11C]- and [18F]-labelled choline derivates is increasingly being used for imaging of primary and recurrent prostate cancer. While PET and PET/CT with [11C]- and [18F]-labelled choline derivates in patients suffering from biochem
Externí odkaz:
https://doaj.org/article/0ecad4ca9c32448d8a98bf4f1e7aa49f
Autor:
J. Reiner, S. Schwarzenböck, T. Lindner, R. Jaster, P. Berlin, B.J. Krause, B. Vollmar, C. Schafmayer, M. Witte, G. Lamprecht, J. Kurth
Publikováno v:
60. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin.
Autor:
M. Heuschkel, J.K. Tietze, J. Kurth, M. Krönert, G. Ojak, P. Grünwald, J. Roewer, P. Troitzsch, A.L. Riedmiller-Schraven, M. Dörschner, B.J. Krause, S. Emmert, S. Schwarzenböck
Publikováno v:
60. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
S. Ziegler, U. Treiber, David H. Sachs, M. Schwaiger, Tibor Schuster, B. J. Krause, S. Schwarzenböck, Hans Wester, M. Souvatzoglou, R. Nawroth, Gregor Weirich, R. Senekowitsch-Schmidtke
Publikováno v:
Nuklearmedizin. 52:141-147
SummaryThe aim of this study was to determine whether [11C]choline can be used for docetaxel therapy response assessment in a LNCaPprostate cancer xenograft mouse model using [11C]choline small-animal PET/CT. Animals, methods: The androgen-dependent
Publikováno v:
Nuklearmedizin. 49:S41-S45
SummaryIn oncology, PET and PET/CT with tracers beyond FDG target more specific biological processes, such as proliferation (18F-3'-fluoro-3'-deoxy-L-thymidine; 18F-FLT), tumour hypoxia (18F-fluoromisonidazol; 18F-FMISO) and phospholipid metabolism (
Publikováno v:
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.... 56(4)
As prostate cancer is the most prevalent form of cancer in men and constitutes the third most common cause of cancer associated deaths, early diagnosis of primary prostate cancer and accurate staging influencing the appropriate choice of therapy is c
Autor:
S, Schwarzenböck, D, Sachs, M, Souvatzoglou, T, Schuster, R, Nawroth, G, Weirich, U, Treiber, H-J, Wester, S, Ziegler, M, Schwaiger, R, Senekowitsch-Schmidtke, B J, Krause
Publikováno v:
Nuklearmedizin. Nuclear medicine. 52(4)
The AIM of this study was to determine whether [¹¹C]choline can be used for docetaxel therapy response assessment in a LNCaP-prostate cancer xenograft mouse model using [¹¹C]choline small-animal PET/CT.The androgen-dependent human prostate cancer
Autor:
Bernd J. Krause, M. Schwaiger, H Kübler, Matthias Eiber, Ernst J. Rummeny, S. Schwarzenböck, M Souvatzoglu, Gregor Weirich
Publikováno v:
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 184
Publikováno v:
Nuklearmedizin. Nuclear medicine. 49
In oncology, PET and PET/CT with tracers beyond FDG target more specific biological processes, such as proliferation (18F-3´-fluoro-3´-deoxy-L-thymidine; 18F-FLT), tumour hypoxia (18F-fluoromisonidazol; 18F-FMISO) and phospholipid metabolism (radio